Authorizes prescription of Schedule II controlled dangerous substances through telemedicine or telehealth without certain in-person requirements.

This bill allows doctors in New Jersey to prescribe certain controlled substances, such as some pain medications, via telemedicine without requiring an in-person visit. It permits providers to use asynchronous methods, like reviewing medical records before a call, as long as they can meet the same standard of care as an in-person appointment. The legislation also mandates that patients be informed if their provider is not a physician and ensures that all telehealth interactions are properly documented and integrated into the patient's medical record.